Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study (Q45161391)
Jump to navigation
Jump to search
scientific article published on 23 November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study |
scientific article published on 23 November 2004 |
Statements
1 reference
Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study (English)
1 reference
Wémeau JL
1 reference
Caron P
1 reference
Beckers A
1 reference
Rohmer V
1 reference
Orgiazzi J
1 reference
Borson-Chazot F
1 reference
Nocaudie M
1 reference
Perimenis P
1 reference
Bisot-Locard S
1 reference
Bourdeix I
1 reference
Dejager S
1 reference
23 November 2004
1 reference
1 reference
90
1 reference
2
1 reference
841-848
1 reference
Identifiers
1 reference
1 reference